Related Experiment Video
Updated: Jun 24, 2025

11:22
Automated Robotic Liquid Handling Assembly of Modular DNA Devices
Published on: December 1, 2017
12.4K
Navigating the 'moral hazard' argument in synthetic biology's application
1ARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, NSW, Australia.
Synthetic Biology (Oxford, England)
|June 3, 2024
Summary
Synthetic biology offers environmental solutions but poses moral hazard risks. This paper outlines strategies to navigate these risks and ensure responsible deployment for better environmental outcomes.
Area of Science:
- Synthetic biology
- Environmental science
- Ethics in technology
Background:
- Synthetic biology holds significant promise for addressing environmental damage.
- However, its deployment may create a moral hazard, where environmentally damaging behaviors are not curtailed or are even exacerbated.
- This risk necessitates careful consideration to prevent worse outcomes than non-deployment.
Purpose of the Study:
- To describe methods for navigating moral hazard arguments related to synthetic biology.
- To provide strategies for mitigating the possibility of moral hazard in synthetic biology applications.
- To enhance the positive public and environmental impact of synthetic biology.
Main Methods:
- Analysis of moral hazard arguments in the context of emerging technologies.
- Development of frameworks for risk assessment and mitigation strategies.
- Case study or theoretical modeling of synthetic biology deployment scenarios.
Main Results:
- Identification of key pathways through which synthetic biology can induce moral hazard.
- Proposed practical strategies for policymakers, industry, and researchers to address these risks.
- Demonstration that proactive management of moral hazard can lead to improved environmental stewardship.
Conclusions:
- Addressing the moral hazard is crucial for realizing the full environmental benefits of synthetic biology.
- Implementing proposed navigation and mitigation strategies can foster responsible innovation.
- Proactive ethical and regulatory frameworks are essential for sustainable synthetic biology development.
Related Concept Videos
Synthetic Biology
4.7K
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Golden rice
Golden rice is a genetically modified...
4.7K
What is Genetic Engineering?
74.0K
Overview
74.0K
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
CRISPR
50.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.6K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Recombinant DNA
94.1K
Overview
94.1K

